Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Renner

Showing results (31-40 of 239) with videos related to

Pageof 24
Sort By:
ACS Medicinal Chemistry Letters|March 18, 2026
Modulation of Cancer Networks through Protein Degradation, DNA Repair Inhibition, and Quantitative InteractomicsAnna C Renner, Robert B Kargbo
ACS Medicinal Chemistry Letters|January 14, 2026
Multidimensional Strategies in Oncology: From Macrocyclic Kinase Inhibitors to Physicochemical and Transcriptomic DiagnosticsAnna C Renner, Robert B Kargbo
ACS Medicinal Chemistry Letters|January 14, 2026
Molecular Diagnostics, Circuit-Calming Modulators, and Controlled Neuroplastogens: Emerging Strategies in Precision Neuropsychiatric TherapeuticsAnna C Renner, Robert B Kargbo
ACS Medicinal Chemistry Letters|December 17, 2025
Dual Innovations in EGFR Degradation and Antigen-Specific Modulation for Multiple SclerosisAnna C Renner, Robert B Kargbo
ACS Medicinal Chemistry Letters|November 19, 2025
Toward Precision Psychedelic Therapies: Chemical, Computational, and Neuromodulatory InnovationsAnna C Renner, Robert B Kargbo
Die Rehabilitation|August 28, 2007
[Immediate effects of therapeutic interventions on the central motor system and their practical consequences]H Woldag, C Renner, H Hummelsheim
Annals of Hematology|January 5, 2002
The future of monoclonal antibody engineeringC Renner, F Hartmann, M Pfreundschuh
ACS Medicinal Chemistry Letters|November 19, 2025
Broadening Degrader Therapeutics: Keap1 PROTACs, Antimalarial Hybrids, and PLK1 Inhibition of NLRP3 InflammasomesAnna C Renner, Robert B Kargbo
ACS Medicinal Chemistry Letters|February 18, 2026
From Solid-State Control to Predictive Precision: Building a Deployable Ecosystem for Psychedelic TherapeuticsAnna C Renner, Robert B Kargbo
ACS Medicinal Chemistry Letters|December 17, 2025
Dual-State KRAS G12C Inhibitors as Emerging Therapeutics for Brain and Lung MetastasesAnna C Renner, Robert B Kargbo
Pageof 24

Showing results (31-40 of 239) with videos related to

Sort By:
Pageof 24
ACS Medicinal Chemistry Letters|March 18, 2026
Modulation of Cancer Networks through Protein Degradation, DNA Repair Inhibition, and Quantitative InteractomicsAnna C Renner, Robert B Kargbo
ACS Medicinal Chemistry Letters|January 14, 2026
Multidimensional Strategies in Oncology: From Macrocyclic Kinase Inhibitors to Physicochemical and Transcriptomic DiagnosticsAnna C Renner, Robert B Kargbo
ACS Medicinal Chemistry Letters|January 14, 2026
Molecular Diagnostics, Circuit-Calming Modulators, and Controlled Neuroplastogens: Emerging Strategies in Precision Neuropsychiatric TherapeuticsAnna C Renner, Robert B Kargbo
ACS Medicinal Chemistry Letters|December 17, 2025
Dual Innovations in EGFR Degradation and Antigen-Specific Modulation for Multiple SclerosisAnna C Renner, Robert B Kargbo
ACS Medicinal Chemistry Letters|November 19, 2025
Toward Precision Psychedelic Therapies: Chemical, Computational, and Neuromodulatory InnovationsAnna C Renner, Robert B Kargbo
Die Rehabilitation|August 28, 2007
[Immediate effects of therapeutic interventions on the central motor system and their practical consequences]H Woldag, C Renner, H Hummelsheim
Annals of Hematology|January 5, 2002
The future of monoclonal antibody engineeringC Renner, F Hartmann, M Pfreundschuh
ACS Medicinal Chemistry Letters|November 19, 2025
Broadening Degrader Therapeutics: Keap1 PROTACs, Antimalarial Hybrids, and PLK1 Inhibition of NLRP3 InflammasomesAnna C Renner, Robert B Kargbo
ACS Medicinal Chemistry Letters|February 18, 2026
From Solid-State Control to Predictive Precision: Building a Deployable Ecosystem for Psychedelic TherapeuticsAnna C Renner, Robert B Kargbo
ACS Medicinal Chemistry Letters|December 17, 2025
Dual-State KRAS G12C Inhibitors as Emerging Therapeutics for Brain and Lung MetastasesAnna C Renner, Robert B Kargbo
Pageof 24